---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-25-000183"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:03:33.646892+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Surgical Q2 revenue up 21% to $2.44B; non-GAAP EPS $2.19 vs $1.78

## Summary
- Revenue $2.44B (+21% YoY); GAAP diluted EPS $1.81; non-GAAP diluted EPS $2.19 (vs $1.46/$1.78 last year).
- da Vinci procedures up ~17%; placed 395 systems including 180 da Vinci 5 (vs 341/70). Installed base 10,488 (+14% YoY).
- Full-year 2025 guidance: procedure growth 15.5%-17%; non-GAAP gross margin 66%-67% (includes ~1% tariff impact).
- EU MDR certification and Japan clearance obtained for da Vinci 5 in July/June 2025.

## SEC filing metadata
- accession: 0001035267-25-000183
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000183/0001035267-25-000183-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000183/isrg-20250722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-25-000183
- JSON: https://secwatch.observer/filing/0001035267-25-000183.json
- Plain text: https://secwatch.observer/filing/0001035267-25-000183.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.